XP® monoclonal antibodies are high quality rabbit monoclonal antibodies exclusively available from Cell Signaling Technology (CST). XP monoclonal antibodies are generated using XMT® technology, a proprietary rabbit monoclonal method developed at CST. This technology provides access to a broad range of antibodies unattainable with traditional monoclonal technologies, allowing more comprehensive screening in the most relevant applications. Products labeled with XP have met additional standards for exceptional performance, including high specificity and sensitivity in one or more key applications and utility for multiple applications.
Case Study 1: Specificity: XP antibodies are highly specific to your target of interest; ensuring accurate and reliable research results and minimizing experimental optimization and reagents.
Case Study 2: Sensitivity: XP antibodies provide a strong signal for your target protein in cells and tissues, allowing you to monitor expression of low levels of endogenous proteins and use less sample to detect highly expressed target proteins.
Case Study 3: Reproducibility: Rabbit monoclonal antibodies developed using XMT technology, show lot-to-lot consistency, which results in long term reproducible results.
Case Study 4: Overall Performance for Multiple Applications: The power of XMT technology coupled with our extensive antibody validation delivers XP monoclonal antibodies with Exceptional Performance in the widest range of relevant research applications.